These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 579844)

  • 21. [Endometrial histology studied in women bleeding with IUD in situ].
    Nesit V; Kyselá T
    Cesk Gynekol; 1975 Jul; 40(6):427-31. PubMed ID: 1157133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The response of endometrial blood vessels to intrauterine contraceptive devices: an electron microscopic study.
    Sheppard BL; Bonnar J
    Br J Obstet Gynaecol; 1980 Feb; 87(2):143-54. PubMed ID: 7362802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Higher fibrinolytic activity in human endometrium in direct contact with an IUD.
    Liedholm P; Srivastava K; Wingerup L; Astedt B
    Acta Obstet Gynecol Scand; 1983; 62(2):169-70. PubMed ID: 6868967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrauterine device and maternal copper metabolism during lactation.
    Rodrigues da Cunha AC; Dorea JG; Cantuaria AA
    Contraception; 2001 Jan; 63(1):37-9. PubMed ID: 11257247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cellular changes in the glandular epithelium of the endometrial and endocervical mucosa of women using the IUD (CU 7 device)].
    Zanetta G; Confalonieri C
    Ann Ostet Ginecol Med Perinat; 1979; 100(6):442-7. PubMed ID: 554521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of the copper intrauterine device on the expression of cyclooxygenase-1 and -2 in the endometrium.
    Xin ZM; Cao LM; Xie QZ; Sun Y; Su YC; Guo YH
    Int J Gynaecol Obstet; 2009 May; 105(2):166-8. PubMed ID: 19230888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uterine histopathologic changes after Cu-Fix intrauterine device insertion.
    Reinprayoon D; Taneepanichskul S; Niruthisard S; Suwajanakon S
    Contraception; 1999 Jan; 59(1):63-5. PubMed ID: 10342087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Use of hysterography as a rapid method for determining complications occurring in the presence of an intrauterine pessary].
    Nalbanski B; Cherveniashki S; Nalbanski B
    Akush Ginekol (Sofiia); 1988; 27(2):58-61. PubMed ID: 3414902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The morphometric study of endometrium during long-term use of TCu220C IUD].
    Zhao Y; He Q
    Zhonghua Fu Chan Ke Za Zhi; 1996 Sep; 31(9):519-22. PubMed ID: 9275420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytologic monitoring of women using copper-containing intrauterine devices: five-year follow-up study.
    Luthra UK; Mitra AB; Prabhakar AK; Agarwal SS; Bhatnagar P
    Acta Cytol; 1982; 26(5):619-22. PubMed ID: 6959449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Intrauterine contraception with bioactive devices. Clinico-statistical experience with a copper-potentiated IUD (Gravigard)].
    Foti A; Carluccio A
    Minerva Ginecol; 1979 Sep; 31(9):629-38. PubMed ID: 395462
    [No Abstract]   [Full Text] [Related]  

  • 32. [Two and half years' experience with the IUD of multiload copper 250].
    Lin JC
    Changgeng Yi Xue Za Zhi; 1988 Mar; 11(1):41-5. PubMed ID: 3416218
    [No Abstract]   [Full Text] [Related]  

  • 33. Ultrastructural alterations in human endometrium caused by intrauterine contraceptive devices.
    Verma V
    Int J Gynaecol Obstet; 1981 Jun; 19(3):211-9. PubMed ID: 6120868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of copper intrauterine device on the cyclooxygenase and inducible nitric oxide synthase expression in the luteal phase endometrium.
    Coskun E; Cakiroglu Y; Aygun BK; Muezzinoglu B; Caliskan E
    Contraception; 2011 Dec; 84(6):637-41. PubMed ID: 22078195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of Copper-IUD on the human endometrium (author's transl)].
    Tamaya T; Nakata Y; Nioka S; Obata T; Higashiyama S; Okada H
    Nihon Funin Gakkai Zasshi; 1978 Jan; 23(1):24-7. PubMed ID: 627299
    [No Abstract]   [Full Text] [Related]  

  • 36. [Prevention of pregnancy by using intrauterine contraceptive devices].
    Toĭvonen Iu
    Akush Ginekol (Mosk); 1990 Dec; (12):53-4. PubMed ID: 2090000
    [No Abstract]   [Full Text] [Related]  

  • 37. A clinicopathological study of IUD users with special reference to endometrial patterns and endometritis.
    van Bogaert LJ
    Gynecol Obstet Invest; 1983; 16(3):129-35. PubMed ID: 6618283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical experience with the copper T-200 intrauterine device].
    Köhler G; Schubel HW
    Zentralbl Gynakol; 1979; 101(7):478-81. PubMed ID: 463411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of action of intrauterine devices: biochemical changes.
    Johannisson E
    Contraception; 1987 Jul; 36(1):11-22. PubMed ID: 3311620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between copper IUD complications and ultrasonographic findings.
    Fadiloglu S; Dilbaz B; Fadiloglu E; Dilbaz S
    Arch Gynecol Obstet; 2018 Apr; 297(4):989-996. PubMed ID: 29428979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.